EXENS — Exosens SAS Share Price
Last trade - 00:00- €4.14bn
- €4.44bn
- €291.82m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 19.63 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 150.19 | ||
| Price to Sales | 12.74 | ||
| EV to EBITDA | 53.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.94% | ||
| Return on Equity | 21.44% | ||
| Operating Margin | 16.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | 149.86 | 166.17 | 200.75 | 291.82 | n/a | n/a | 24.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +886.02 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EXOSENS SAS is a France-based company which is a manufacturer and seller of technologies in the field of particles and photo detection and imaging intended to serve space, research, defense and commercial clients. The Company designs, produces and markets electro-optic components and devices including sensors and optics for the detection and amplification of low light, radiation, and emissions. It offers detectors and detection solutions: such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes to respond to complex issues in environment.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- March 16th, 2021
- Public Since
- June 7th, 2024
- No. of Employees
- 1,232
- Sector
- Electronic Equipments & Parts
- Industry
- Technology
- Exchange
- Euronext - Paris
- Shares in Issue
- 194,965,632
- Address
- Dom De Pelus Axis Business Park, MERIGNAC, 33700
- Web
- https://www.exosens.com/
- Phone
- +33 555863700
- Auditors
- PricewaterhouseCoopers Audit
Similar to EXENS
Arcure SA
Euronext - Paris
BALYO SA
Euronext - Paris
Munic SA
Euronext - Paris
NSE SA
Euronext - Paris
Prodways SA
Euronext - Paris
FAQ
As of Today at 20:37 UTC, shares in Exosens SAS are trading at €20.95. This share price information is delayed by 15 minutes.
Shares in Exosens SAS last closed at €20.95 and the price had moved by over the past 365 days. In terms of relative price strength the Exosens SAS share price has matched the FTSE Global All Cap Index by over the past year.
There is no consensus recommendation for this security.
Exosens SAS does not currently pay a dividend.
Exosens SAS does not currently pay a dividend.
Exosens SAS does not currently pay a dividend.
To buy shares in Exosens SAS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €20.95, shares in Exosens SAS had a market capitalisation of €4.08bn.
Here are the trading details for Exosens SAS:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: EXENS
Based on an overall assessment of its quality, value and momentum Exosens SAS is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Exosens SAS. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of €20.95, shares in Exosens SAS were trading -3.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Exosens SAS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €20.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Exosens SAS' directors